Method and compound for the treatment of covid-19

Abstract

A method for the treatment of COVID-19, including administering to a subject in need thereof of a medicinal herbal compound, such that the medicinal herbal compound is a glycol derivative.

1 . A method for the treatment of COVID-19, comprising:
 administering to a subject in need thereof of a medicinal herbal compound,   such that the medicinal herbal compound is a glycol derivative.   
     
     
         2 . The method of  claim 1 , wherein the glycol derivative is diethylene glycol dibenzoate. 
     
     
         3 . The method of  claim 1 , wherein the medicinal herbal compound is immunogenic with unique multiple modes of action. 
     
     
         4 . The method of  claim 1 , wherein the medicinal herbal compound is at least one of thermodynamic, hydrophobic, electric, and stereo-geometric. 
     
     
         5 . The method of  claim 1 , wherein the medicinal herbal compound migrates from blood into tissue. 
     
     
         6 . The method of  claim 1 , wherein the medicinal herbal compound has less than 3.5 argon root-mean-square deviation while interacting with a residue. 
     
     
         7 . The method of  claim 1 , wherein the medicinal herbal compound is a nucleoside analog. 
     
     
         8 . The method of  claim 1 , wherein the medicinal herbal compound binds to a protein-ligand complex using less than 5 kcal/mol. 
     
     
         9 . The method of  claim 1 , wherein the medicinal herbal compound stimulates production of gamma interferon equivalent to a PMA-lonomycin combination.